Related Experiment Video
Updated: Mar 14, 2026

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
A randomized crossover study comparing membrane and centrifugal therapeutic plasma exchange procedures
Petar Kes1, Michiel Etienne Janssens2, Nikolina Bašić-Jukić1
1Department of Nephrology, Arterial Hypertension, Dialysis and Kidney Transplantation, University Hospital Centre Zagreb, and Faculty of Medicine, University of Zagreb, Zagreb, Croatia.
The Spectra Optia centrifuge-based system offers more efficient and significantly shorter therapeutic plasma exchange (TPE) procedures compared to the Diapact membrane-based system. Both systems provide safe and adequate TPE, but Spectra Optia excels in plasma removal efficiency.
Area of Science:
- Nephrology
- Hematology
- Medical Devices
Background:
- Therapeutic plasma exchange (TPE) is a critical procedure with two main system types: membrane-based (mTPE) and centrifuge-based (cTPE).
- Limited comparative studies exist for TPE devices, particularly for the membrane-based Diapact and centrifuge-based Spectra Optia systems.
- This study provides the first randomized data comparing the Diapact (mTPE) and Spectra Optia (cTPE) devices.
Purpose of the Study:
- To conduct the first randomized head-to-head comparison of membrane-based (Diapact) and centrifuge-based (Spectra Optia) therapeutic plasma exchange systems.
- To evaluate and compare the plasma removal efficiency (PRE), total procedure time, and removal efficiencies of blood cells, IgG, and fibrinogen between the two TPE systems.
- To assess the safety and adequacy of TPE procedures performed on both devices.
Main Methods:
- A randomized prospective study involving 27 patients comparing mTPE (Diapact) and cTPE (Spectra Optia) systems.
- Standardized TPE procedures were performed on both devices.
- Key metrics analyzed included plasma removal efficiency (PRE), total procedure time (including setup and priming), and removal efficiencies for blood cells, IgG, and fibrinogen.
Main Results:
- Both systems achieved adequate plasma removal, but the Spectra Optia (cTPE) was significantly faster, with a mean procedure time of 101.5 minutes compared to 157 minutes for the Diapact (mTPE).
- The Spectra Optia demonstrated higher plasma removal efficiency (83.0%) than the Diapact (53.2%).
- While IgG and blood cell removal efficiencies were similar, the Spectra Optia was more effective at removing fibrinogen (72.3%) compared to the Diapact (62.9%).
Conclusions:
- Both membrane-based (Diapact) and centrifuge-based (Spectra Optia) systems are safe and adequate for therapeutic plasma exchange.
- The Spectra Optia system offers significantly shorter procedure times and higher plasma removal efficiency compared to the Diapact system.
- The findings suggest the Spectra Optia may be a more efficient choice for TPE procedures requiring substantial plasma removal.
More Related Videos
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.

